About this trial
In our study, the investigators sought to answer the question of how the retroglossal pharyngeal areas measured after extubation of patients compare to baseline (before muscle relaxation) values. The investigators also investigated how these areas change as a function of TOF ratios measured at extubation, thus looking for a correlation between residual muscle relaxant effect and airway area.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
ASA 1-3;
BMI 18.5-25 (normal body weight);
men/women in equal proportion;
duration of surgeries at least ≥ 30 minutes;
Disqualifiers
drugs affecting neuromuscular function (magnesium, aminoglycosides);
difficult airway, expected difficult intubation;
pregnancy (pregnancy test for women of childbearing age to rule out pregnancy we finish);
breastfeeding;
Trial population
Patients who receive a muscle relaxant (rocuronium bromide) for their operation to aid intubation and surgical exploration.
Trial design
Case-only
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
The differences in retroglossal pharyngeal cross sectional areas (inspiration and exspiration) measured at different TOF values
The differences in retroglossal pharyngeal cross sectional areas (inspiration and exspiration) measured at different train of four TOF values, and changes in these values compared to (initial) retroglossae pharyngeal areas detected before administration of muscle relaxants. Areas are measured in pixels and the rate of reduction of areas is expressed as a percentage.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Tamas Vegh, MD
Lead sponsor
University of Debrecen
Sponsor institution